Developed cancer drug for 'western patients' who could afford, not 'for Indians': Bayer's CEO

[arp2041]

Come back at me, when india reached our technological level. You wont reach it with stealing though.

And i dont smoke, im an athlete.

That will be very helpful for you when the war between India & Italy will start.............You will be needing it to cross over to France.

 

[pursuit of happiness]

He critiszed that there is no freedom, that women are treated like animals and that there is a gigantic division between rich and poor. He said to students in a speech to fight the backwarded elements of their society, participate in their future.

You can read the article on the Spiegel magazine

---------------------------
what you said,
He critiszed - yes
He critiszed that there is no freedom, that women are treated like animals and that there is a gigantic division between rich and poor
what german president said,,
German President Gauck has criticized violence against women and the situation of homosexuals in the South Asian country
-----
what you said, -
He said to students in a speech to fight the backwarded elements of their society, participate in their future.
what german president said,,
Addressing students at Delhi's Jawaharlal Nehru University, the German president stressed how difficult it was for citizens to exercise their rights, "given the traditional behaviors" in the country. Gauck repeatedly referred to women's rights issues and the situation of homosexuals in India as two "extremely sensitive topics."

Gauck praises Indian rights activists

German head of state praised the country's vibrant civil society and media, saying there was nothing that Indians didn't know or hadn't already discussed
what you said,
He critiszed that there is no freedom, that women are treated like animals and that there is a gigantic division between rich and poor
what german president said,,
i cant find anything PRESIDENT said like that..

can you please let me know where you read this in article.

there are some comments by social activist on women right which are true and we are taking care of it..

--
Summary..

German head of state praised the country's vibrant civil society and media, saying there was nothing that Indians didn't know or hadn't already discussed
india also have some issue with homosexuality and women right which we ARE working for it

DONT POST WHAT YOU THINK AS PRESIDENT COMMENTS

but where he discussed CL-WTO and IPR..
as per you india is thief.. it took your knowledge... your hardwork.. so german president will make india accountable for it..

 

[MarkusS]

You are working on nothing. I see 0 improvement. But don´t worry, your country matters are irrelevant for me. If you think killing women and homosexuals is ok...thats not my business.

 

[pursuit of happiness]

You are working on nothing. I see 0 improvement. But don´t worry, your country matters are irrelevant for me. If you think killing women and homosexuals is ok...thats not my business.

please answer the question dear...
i take time to improve..i am very slow learner but i learn
thanks,, no one told you to think about our country..
Killing women and homosexual? again somthing new theory.. ok.. please post the link.. as you know no link then fly in black hole..
please answer question which you raised ... i answered with your own link

waiting for your reply on my points mention in previous post..post no.542

 

[Daedalus]

Global doctors association slams US for pressuring India on pharma

A Geneva-based non-profit doctors association has criticised the US and its pharma lobby for exerting pressure on India for its patent laws, saying such actions undermine the global trading system.

"Every country has the right to take steps to increase access to medicines and implement a patent system in line with its public health needs. We strongly object to the pressure exerted by the US on developing countries, including India, for using legal flexibilities to protect public health," Rohit Malpani of the Doctors Without Borders told the US International Trade Commission yesterday.

USITC has conducted a hearing this week in connection with its investigation "Trade, Investment, and Industrial Policies in India: Effects on the US Economy".

"India's measures are fully compliant with global trade rules and with the laws of India. These attacks undermine the global trading system as well as the independence of the Indian judiciary, which was responsible for the decisions under discussion today," Mr Malpani told the USITC members.

The measures India has implemented to safeguard public health are of critical importance to protect the health of millions of people across the world. India has been nicknamed the "pharmacy to the developing world" in recognition of this fact, he said.

"Losing this 'pharmacy' would be devastating for patients and for treatment providers," he said and urged USITC to evaluate the decisions made by the Indian government under international trade rules taking in to consideration its impact on public health.

Taking to task the strong US pharma lobby, which in the past one year has launched a campaign against India, the Doctors Without Border representatives said relying on high prices for medicines backed up by intellectual property monopolies is a flawed paradigm to pay for medical innovation.

"It creates both access problems due to high prices - as we have seen - and at the same time it does not stimulate innovation for many of the diseases affecting people in developing countries, where patients have limited purchasing power and the private sector sees no incentive," Mr Malpani said.

"Today, we basically have a tradeoff between innovation and access. If you have wide access, says the industry, you aren't supporting innovation," he said.

"Seeking greater intellectual property norms in countries like India that are the source of access for millions around the world, not only does little for innovation but it perpetuates a failed business model," Mr Malpani said.

"Instead of aggressively pushing governments, such as India, to ignore its legal rights under international trade rules to ensure affordable medicine prices, the US government should work with India and other countries, to invest in and develop new models of innovation that promote both innovation and access," he said.

Global doctors association slams US for pressuring India on pharma - NDTVProfit.com

 

[Indo-guy]

Global doctors association slams US for pressuring India on pharma

A Geneva-based non-profit doctors association has criticised the US and its pharma lobby for exerting pressure on India for its patent laws, saying such actions undermine the global trading system.

"Every country has the right to take steps to increase access to medicines and implement a patent system in line with its public health needs. We strongly object to the pressure exerted by the US on developing countries, including India, for using legal flexibilities to protect public health," Rohit Malpani of the Doctors Without Borders told the US International Trade Commission yesterday.

USITC has conducted a hearing this week in connection with its investigation "Trade, Investment, and Industrial Policies in India: Effects on the US Economy".

"India's measures are fully compliant with global trade rules and with the laws of India. These attacks undermine the global trading system as well as the independence of the Indian judiciary, which was responsible for the decisions under discussion today," Mr Malpani told the USITC members.

The measures India has implemented to safeguard public health are of critical importance to protect the health of millions of people across the world. India has been nicknamed the "pharmacy to the developing world" in recognition of this fact, he said.

"Losing this 'pharmacy' would be devastating for patients and for treatment providers," he said and urged USITC to evaluate the decisions made by the Indian government under international trade rules taking in to consideration its impact on public health.

Taking to task the strong US pharma lobby, which in the past one year has launched a campaign against India, the Doctors Without Border representatives said relying on high prices for medicines backed up by intellectual property monopolies is a flawed paradigm to pay for medical innovation.

"It creates both access problems due to high prices - as we have seen - and at the same time it does not stimulate innovation for many of the diseases affecting people in developing countries, where patients have limited purchasing power and the private sector sees no incentive," Mr Malpani said.

"Today, we basically have a tradeoff between innovation and access. If you have wide access, says the industry, you aren't supporting innovation," he said.

"Seeking greater intellectual property norms in countries like India that are the source of access for millions around the world, not only does little for innovation but it perpetuates a failed business model," Mr Malpani said.

"Instead of aggressively pushing governments, such as India, to ignore its legal rights under international trade rules to ensure affordable medicine prices, the US government should work with India and other countries, to invest in and develop new models of innovation that promote both innovation and access," he said.

Global doctors association slams US for pressuring India on pharma - NDTVProfit.com

India has to do away with this pressure tactics from MNCs and their spokesperson i.e. US government .

Action of Indian government has sanction of Apex court ...

We should use our right to issue compulsory license in interest of public health appropriately .

Let them contest our action in WTO which is the final arbiter .

 

[amitkriit]

Global doctors association slams US for pressuring India on pharma

A Geneva-based non-profit doctors association has criticised the US and its pharma lobby for exerting pressure on India for its patent laws, saying such actions undermine the global trading system.

"Every country has the right to take steps to increase access to medicines and implement a patent system in line with its public health needs. We strongly object to the pressure exerted by the US on developing countries, including India, for using legal flexibilities to protect public health," Rohit Malpani of the Doctors Without Borders told the US International Trade Commission yesterday.

USITC has conducted a hearing this week in connection with its investigation "Trade, Investment, and Industrial Policies in India: Effects on the US Economy".

"India's measures are fully compliant with global trade rules and with the laws of India. These attacks undermine the global trading system as well as the independence of the Indian judiciary, which was responsible for the decisions under discussion today," Mr Malpani told the USITC members.

The measures India has implemented to safeguard public health are of critical importance to protect the health of millions of people across the world. India has been nicknamed the "pharmacy to the developing world" in recognition of this fact, he said.

"Losing this 'pharmacy' would be devastating for patients and for treatment providers," he said and urged USITC to evaluate the decisions made by the Indian government under international trade rules taking in to consideration its impact on public health.

Taking to task the strong US pharma lobby, which in the past one year has launched a campaign against India, the Doctors Without Border representatives said relying on high prices for medicines backed up by intellectual property monopolies is a flawed paradigm to pay for medical innovation.

"It creates both access problems due to high prices - as we have seen - and at the same time it does not stimulate innovation for many of the diseases affecting people in developing countries, where patients have limited purchasing power and the private sector sees no incentive," Mr Malpani said.

"Today, we basically have a tradeoff between innovation and access. If you have wide access, says the industry, you aren't supporting innovation," he said.

"Seeking greater intellectual property norms in countries like India that are the source of access for millions around the world, not only does little for innovation but it perpetuates a failed business model," Mr Malpani said.

"Instead of aggressively pushing governments, such as India, to ignore its legal rights under international trade rules to ensure affordable medicine prices, the US government should work with India and other countries, to invest in and develop new models of innovation that promote both innovation and access," he said.

Global doctors association slams US for pressuring India on pharma - NDTVProfit.com

India must tell the US that if the drama continues for too long, the US MNCs might be asked to take a hike (in fact the Indian Ambassador to the US has said something on similar line). There is no scarcity of the companies willing to do business with India.

 

[Daedalus]

India has to do away with this pressure tactics from MNCs and their spokesperson i.e. US government .

Action of Indian government has sanction of Apex court ...

We should use our right to issue compulsory license in interest of public health appropriately .

Let them contest our action in WTO which is the final arbiter .

India must tell the US that if the drama continues for too long, the US MNCs might be asked to take a hike (in fact the Indian Ambassador to the US has said something on similar line). There is no scarcity of the companies willing to do business with India.

Our Supreme court have already said everything in their verdict on Nexavar. They have already told them to take a hike.

“We are not inclined to interfere with the order of Controller General in the interest of the public. The invention must be available to the public at reasonable and affordable price if not compulsory licence is given.”

“We must bear in the mind of public interest but neither the investor nor the compulsory licence applicant. Patents are granted to benefit the inventions to the public.”

Natco Pharma wins cancer drug case - The Hindu

 

[Daedalus]

Here is some more salt to rub on their wounds, can any pharma company afford to back out of Indian market with these kind of predictions.

Pharma sales in India to touch $27 bn by 2016: Deloitte
Pharmaceutical sales in India are expected to rise by 14.4 per cent to USD 27 billion in 2016 from last year, but the life sciences and health care industry is up against challenges such as quality management and meeting global standards, says a report.

Pharma sales in India to touch $27 bn by 2016: Deloitte - Financial Express